Loading quotes...

Forecast

There is no analyst data available for this company.

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics
In 2026, Boiron has already paid €1.35 in dividends. The last payout was in June.

Financials

In the last quarter, Boiron had revenue of €240.32M and net profit of €4.91M
(EUR) June 2026
YoY
Revenue 240.32M -
Gross profit 173.27M -
Net profit 4.91M -
EBITDA 21.01M -

Fundamentals

Metric Value
Market capitalization
€309.92M
Number of shares
17.36M
52-week high/low
€56.50 - €17.35
Dividend yield
7.61%
Dividends TTM
€1.35
Beta
0.22
P/E ratio
12.05
PEG ratio
0.35
P/B ratio
0.83
P/S ratio
0.63

Company profile

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and Sédatif PC to treat anxiety and emotional, and minor sleep disorders. The company's homeopathic medicines also comprise Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; and Homéovox for vocal disorders. In addition, it provides dietary supplement; Dermoplasmine stick, baume, and mousse to treat dry lips and skin; Mag' Nuit, a formula to fall asleep; Arnitrosium for joint pain; Castor Equi Boiron ointment for treatment of cracked skin; and Storinyl, a syrup to treat colds. Further, it offers herbal medicines, such as Canephron to increase the amount of urine and to improve urinary elimination; moisturizing baby milk; and medical devices, including a range of COVID self-tests and rapid antigenic tests. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.

Name
Boiron
CEO
Pascal Houdayer
Headquarters Messimy, ara
France
Website
Sector
Health Care
Industry
Pharmaceuticals
IPO
01/03/1991
Employees 2,634

Ticker symbols

Exchange Symbol
Euronext
BOI.PA
London Stock Exchange
0DTF.L
Frankfurt
BON.F
Düsseldorf
BON.DU
London
0DTF.L
Paris
BOI.PA
München
BON.MU
🍪

Parqet  uses cookies. Learn more